Alumina Trihydrate Market Will Generate Revenue, Totaling US$ 4 Bn In 2021 & Market Is Forecast To Exhibit CAGR Of 7.7% During The Forecast Period

Alumina trihydrate sales reached 6724.7 KT in 2021, which are likely to see a healthy 4.5% Y-o-Y increase in 2021. Future Market Insights (FMI) indicates that the gains will remain highly influenced by the increasing use of plastics in the automotive and transportation industry. The industrial application of alumina trihydrate in chemicals, plastics, paper, paints and coatings, among others.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-335

Captive consumption has been an important trend in the alumina trihydrate landscape. While over 70% of alumina trihydrate production is dedicated to captive consumption by manufacturers, the rest is directed to end-use sectors operating within paints & coatings, paper, plastics, construction, and a few other industries.

Plastics and chemicals will remain the key end users of alumina trihydrate, which currently account for more than 60% shares in the market. Consumption of alumina trihydrate in production of alum will particularly remain the prominent point of revenue generation over the forthcoming years. Widening applicability across a multitude of industrial verticals will enable this high-volume market to demonstrate an impressive growth curve through the next decade.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-335

According to report findings, end use of alumina trihydrate in plastics is anticipated to contribute for significant value shares, which has primarily resulted from the increasing applications of alumina trihydrate in engineering plastics. Chemicals, on the other side, are expected to maintain the lead in terms of end use, which is driven by the production of aluminum sulphate (alum) and aluminum chloride. Alum and aluminum chloride find major application as a coagulant in the water treatment sector.

APEJ Market’s Attractiveness Rising

Regions such as North America and APEJ are anticipated to hold significant market shares in terms of value. However, the APEJ market is anticipated to project lucrative growth in the global alumina trihydrate market during the forecast period of 2021-2031. This growth is driven by the rising usage of alumina trihydrate in end-use industries such as plastics, chemicals, papers, paints and coatings of APEJ that include India and China countries, among others. Countries such as China and India have shown positive economic growth.

Furthermore, owing to the effects of macroeconomic factors such as growing population, urbanization, and rapid industrialization, the confidence of investors for investments in housing and other residential projects have increased drastically in South Asia. As a consequence, the building and construction industry of South Asia has gained a significantly positive momentum during the past years, which has increased the consumption of pigments and coatings, and is anticipated to result in the lucrative growth of alumina trihydrate consumption in the South Asia region.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-335

Alumina Trihydrate Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as key participants in the global alumina trihydrate market. Some of the examples of key players in the global alumina trihydrate market are Sumitomo Chemical Co. Ltd., Aluminum Corp. of China Ltd., Nabaltec AG, National Aluminium Company Ltd., Huber Engineered Materials, Almatis GmbH, and Albemarle Corporation, among others.

The global alumina trihydrate market is significantly consolidated with some players holding prominent shares of the market. These participants are offering alumina trihydrate under their popular brands such as Micral, Hymod, MoldX, Hydral, SpaceRite, Vertex, and Zerogen among others.

This FMI study offers market growth forecast for the 10-year assessment period, 2021-2031, and projects a strong 7.7% CAGR for market revenues through 2031.

Sulphur Coated Urea Market Revenues to Reach US$ 855 Mn in 2016

The global sulphur coated urea market is primarily driven by a few factors that include growing concerns about sustainability and cost minimization in the agriculture sector, stringent regulations on conventional fertilizers, increasing number of recreational arenas across the world that require turf grass such as golf courses and concerns about eutrophication. Furthermore, growing urbanization and increase in food consumption globally are also influencing demand for sulphur coated urea.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-938

Increasing urbanization, coupled with spending preferences on luxury amenities, has widened the application area for sulphur coated urea and catalyzed its demand worldwide. Owing to a substantial increase in the number of high-net-worth individuals, the trend of growing investments on recreational and sporting activities is expected to increase. Worldwide focus as well as development in sports infrastructure is paving the way for increased demand for sulphur coated urea owing to its complementary properties in non-agricultural activities.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-938

Market Segments

By region, North America and Asia Pacific Excluding Japan (APEJ) dominated the global sulphur coated urea market in 2015 in terms of revenue, together accounting for over 60% share of the overall market. APEJ and Latin America are forecast to expand at a relatively high CAGR during the forecast period.

Key players in the market are focusing on expanding their footprints in emerging markets largely through mergers and acquisitions. Consolidation in the sulphur coated urea industry has facilitated market leaders, such as Agrium Inc., to expand their businesses in various geographies, thereby increasing their market share.

By product type, polymer sulphur coated urea segment accounted for over 90.0% of the overall sulphur coated urea market in 2015 both in terms of value and volume. Expanding at a CAGR of around 4% over the forecast period, the segment is projected to dominate the market over 2016–2026.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-938

Competitive Landscape

Key market players covered in the report include Agrium Inc., Israel Chemicals Ltd., Syngenta AG, Andersons Inc., Yara International ASA, Harrell’s LLC, Koch Industries Inc., Haifa Chemicals Ltd., and J. R. Simplot Company. Most players in the market are engaged in various activities such as mergers and acquisitions, increasing investments in technological developments, geographical expansion and brand building via strong marketing strategies in order to sustain their position in the competitive market.

Global Laser Safety Glass Are Projected To Reach 6.3 Mn Units By The End Of 2029 & Robust 10% Volume CAGR During The Forecast Period 2019-2029

The global sales of laser safety glass are projected to reach 6.3 Mn units by the end of 2029, which translates into a robust 10% volume CAGR during the forecast period (2019-2029). A new Future Market Insights (FMI) report says that sales of laser safety glass are primarily driven by the growing usage of laser machines across end-use sectors. Laser safety glass is widely used in the healthcare industry, particularly dentistry and dermatology. Strict government regulations about the usage of personal protection equipment will remain crucial in fostering the demand for laser safety glass.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-885

Key Takeaways – Laser Safety Glass Market Study

  • Stringent regulations related to laser safety glass will drive the demand for laser safety glass in the global market. For instance, European standard (EN) 207:20091 outlines the requirement of laser safety glass to ensure workers’ safety and protection. This standard dictates that laser safety glass should be able to withstand 100 pulses from a pulsed laser or a continuous beam for at least 10 seconds, without any damage.
  • With the initiation of shorter pulsed and femtosecond lasers, eyewear protection has become increasingly more important because of the broadband nature of these sources. This factor is expected to significantly drive the demand for laser safety glass.
  • Laser safety glass are required in the military for self-protective purposes against enemy laser attacks and for defense from internal factors as well. Internal usage includes non-combat applications such as industrial, medical, logistics, weapons training, and research and development.
  • Furthermore, laser safety glass is also used for metal fabricating processes such as cutting, engraving, welding, 3D printing, and additive manufacturing.
  • The rapidly growing automotive industry in emerging economies such as China, India, and Brazil is further fueling the demand for laser safety glass.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-885

The market for laser safety glass is currently growing at a moderate pace as is a mature market in EU countries. However, it is showcasing healthy growth in Asian region. The market growth will be aided by enforcement of OSHA regulations in industrial engineering and workplace processes and other sites where the personnel are subjected to high intensity laser emissions and interferences. In terms of new end use verticals, defense will be a lucrative sector, encouraging new entrants in the market.

How is Market Structure Defined?

Dominated by established international players, the laser safety glass market is a consolidated one. Some of the key players in the laser safety glass market such as 3M, Honeywell International Inc., and Philips Safety Products Inc. hold a major share of market pie in terms of revenue, backed by long-term partnerships with consumers and well-established sales network across the continent.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-885

Know More About What the Report Covers

Future Market Insights (FMI), in its new global laser safety glass report, brings to fore an even-handed analysis of the global laser safety glass market, offering comprehensive information with historical demand data for 2014-2018, and forecast statistics for 2019-2029. The research study offers insightful aspects of the global laser safety glass market based on various categories such as technology (glass laser eyewear safety, polycarbonate safety glass, thin film glass, laser protective face shields, intense pulse light glass), application (automotive, medical, chemicals, military & defence, others), and region (North America, Latin America, Eastern Europe, Western Europe, Middle East and Africa, Asia Pacific Excl. Japan, and Japan).

IV Disinfecting Caps Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2031

IV Disinfecting Caps Market is looking forward to grow at a higher rate in the forecast period of 2021-2031. It is estimated that nearly, 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs). IV caps are most useful in avoiding hospital acquired infections and helps hospital staff to protect themselves.

The IV disinfecting caps market is said to grow steadily as the increase in number of hospital admissions and infections that can be easily affected to the people in it. Society for Healthcare Epidemiology of America (SHEA) and other top infection-control organizations in 2014 recognized the use of disinfection caps for hospitals.

What is driving Demand for IV Disinfecting Caps Market?

The demand for IV Disinfecting Caps Market has seen at a higher rate at a global level as there has increase in the number of diseases that leads into surgery. Furthermore, the rising ageing population and lack of hygiene is expected to drive the market. According to a CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14055

Precautions and sanitation measures have been driving the market at a pace.  Globally, this diseases are more prone towards people with low immunity. The demand of IV Disinfecting Caps Market is on to the higher as Government is indulging into keeping the hospitals clean to avoid HAIs. Rise in cancer deaths every year has brought attention to parenteral nutrition, says WHO which leads to increase in demand for the IV Connectors. These reasons have said to be the driving factors for the market in the given forecast period 2021-2031.

U.S. IV Disinfecting Caps Market Outlook

U.S. is said to be the most dominating in terms of disease growth rate and will be the top one to boost the IV Disinfecting Caps Market. This is due to the rising number in the health diseases, and immunocompromised patients. According to CDC histoplasmosis is the commonest disease seen in HIV/ AIDS patients and due to their immunocompromised state 30% of them result in death.

This can be an opportunistic driving factor for the treatment market to grow. In addition, rising R&D and technological advancement in the region are some of the drivers of IV Disinfecting Caps Market. Ivera Medical Corporation, got approved with its Curos® disinfecting port protector, in January 2012, and it has been taking efforts in constantly improving its product. ICU Medical signed definitive agreement to acquire Pursuit Vascular, Inc. in January 2008.

Europe Demand Outlook for IV Disinfecting Caps Market

European Centre for Disease Prevention and Control (ECDC) in 2018, prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year. The increasing focus on the healthcare facility, increase in the population of above 65 age group is likely to drive the market growth.

Furthermore, the growing chronic diseases which diminishes the immunity of a person and AIDS in the region are boosting the demand of IV Disinfecting Caps Market. Centre’s for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. This has hiked the growth of the demand of disinfecting caps.

Who are the Key Manufacturers and Suppliers of IV Disinfecting Caps Market?

Some of the key players operating in the IV Disinfecting Caps Market are

  • Phenomenome Discoveries Inc.
  •  Human Metabolome Technologies, Inc.
  • Thermo Fisher Scientific, Inc.,
  •  Bio- Rad Laboratories, Inc.
  •  Biocrates Life Sciences AG
  • Agilent Technologies, Inc
  •  Merit Medical
  • BD
  • 3M

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

IV Disinfecting Caps Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14055

Key Segment

By Product Type:

  • Single Cap
  • Double Cap

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Centre’s
  • Others

By Application:

  • Blood Collection,
  • Blood Transfusion
  • Infusion

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Testosterone Injectable Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2031

According to the latest research by Future Market Insights, the Testosterone Injectable Market is set to witness a growth of 4.1% CAGR during the year 2021-2031. Testosterone injectable market is one of the most important classes of hormone injectable therapy adopted globally.

Testosterone injectable market is gaining acceptance among patients and physicians due to increasing awareness regarding benefits and efficacy of testosterone replacement therapy products.

The primary male hormone responsible for improving male sexual traits, spermatogenesis, and fertility is testosterone. Erectile dysfunction is caused by a lack of testosterone production, which can be treated with testosterone injectable.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14052

What is Driving Demand for Testosterone Injectable Market?

The demand for testosterone injectable market is largely based on the rise in geriatric population with high risk of testosterone deficiency, growing awareness about testosterone injectable, improved health care infrastructure, policies, and advancement in health care infrastructure. Moreover, access to various diagnostic and treatment services has improved in the recent past, especially in developed economies and this is one of the major factor that has boosted the demand for testosterone injectable market.

The U.S. Testosterone Injectable Market Outlook

The market for testosterone injectable is most prominently driven by countries like U.S. According to a study published in the European Association of Urology Journal, testosterone treatment patterns in the United States have increased by 1.8 to 4-fold in the last two decades.

Moreover, there is an increasing number of people suffering from hypogonadism, growing geriatric population and growing availability of effective and convenient treatment options results in an increasing demand for testosterone injectable in the U.S. The U.S. is undertaking a variety of attempts to strengthen their research and development facilities to fulfil the demand for testosterone injectable.

Europe Demand Outlook for Testosterone Injectable Market

As per a study published in the National Center for Biotechnology Information (NCBI), approximately 30% of men worldwide are affected by hypogonadism. Europe accounts for the existence of numerous medical centers, robust healthcare infrastructure, and increasing government initiative.

Furthermore, rising rise in the incidence of testosterone deficiency, increase in geriatric population with high risk of testosterone deficiency, and increasing awareness about testosterone substitute therapy are the key driving factors in testosterone injectable market in Europe.

Who are the Key Manufacturers and Suppliers of Testosterone Injectable Market?

The key companies working in testosterone injectable and solutions for testosterone injectable are

  • Clarus Therapeutics
  • Bayer AG
  • Endo Pharmaceuticals Inc.
  • Eli Lilly Company
  • Kyowa Kirin International plc
  • Mylan N.V.
  • Novartis AG
  • and Pfizer Inc.
  • J & K Scientific Ltd.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14052

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Bioprocess Technology Market is expected to register a CAGR of 15.2% during 2021-2031

According to a recent study by Future Market Insights (FMI), the global bioprocess technology market was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031.

Technology has always been at the heart of biotech. The emergence of advanced computing technology such as machine learning and artificial intelligence has enabled companies to expand the scale of their research and improve efficiency in the manufacturing process—both of which reduce the time it takes for biotech firms to bring new products to market.

Increasing research and development spending on pharmaceutical products has improved the well-being of patients to a significant level. Today vaccines have proven to be one of the most effective ways to prevent children from infectious diseases. This is highly possible due to increased government spending on research & development in the life science stream.

For instance, in May 2020, AbSci Inc. closed USD 15.4 Mn in series D funding to accelerate the growth and scale of disruptive protein printing technology, by announcing an exclusive co-marketing partnership with KBI Biopharma.

There are currently more than 1,500 biomolecules undergoing clinical trials, which target more than 100 hundred types of diseases and success rate for biologics has so far been over twice that of small-molecule products.

Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13890

Key Takeaways from Bioprocess Technology Market Study

  • In 2021, the BIOTECH/BIOPHARMACEUTICAL COMPANIES segment is expected to dominate the global bioprocess technology market with a 44.0% market share, whereas, CDMO/contract research organization segment is expected to occupy over 40% of the market share.
  • By product, the upstream segment dominated the global Bioprocess Technology market with a 64.8% market share.
  • Europe and East Asia dominated the global bioprocess technology market occupying over 24.3% and 14.7% market share, respectively.

 “Single-use bioprocess products offer lucrative investment opportunities. With the increasing biopharmaceutical manufacturing across the world, adoption of single-use products is expected to gain traction,” says the FMI Analyst

Bioprocess Technology Market

Who is winning?

Some of the leading companies of bioprocess technology are focusing on their extensive portfolio of single-use cell culture bioreactors, containers, strong distribution channels, and strategic selling to the leading biopharmaceutical manufacturing entities.

  • Thermo Fisher Scientific Inc. is a multinational biotech company that develops, manufactures, and distributes products in the areas of healthcare & diagnostics, life sciences, pharmaceuticals, and others. In Sep 2020, Thermo Fisher Scientific Inc. announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
  • Sartorius AG is a leading provider of contract testing services to the global biotechnology and biopharmaceutical industries. In July 2020, Sartorius Stedim Biotech acquired a majority stake in CellGenix to strengthen its product portfolio for cell and gene therapies.
  • Danaher Corporation designs manufacture and markets professional, medical, industrial, and commercial products and services. In March 2020 Danaher Corporation acquired the Biopharma business from General Electric’s Life Sciences division.

The key market players covered by FMI include Thermo Fisher Scientific Inc, Sartorius, Merck KGa, Danaher Corporation, Applikon Biotechnology B.V., Lonza AG, Bio-Rad Laboratories, Agilent technologies, Solida Biotech GmBH, and Waters Corporation.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global bioprocess technology market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the bioprocess technology segment based on product type (upstream equipment, downstream equipment), end-users (biotech/biopharmaceutical companies, CDMO/contract research organization, research/academic institutes), and across seven major regions.

Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13890

Key Questions Answered in Report

  • How much is the bioprocess technology market worth?

The global bioprocess technology market was valued at US$ 17,296.4 Mn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81,215.7 Mn by the end of 2031.

  • What is the demand outlook of the global bioprocess technology market?

The global bioprocess technology market is projected to register high demand in the forecast period and rise at a CAGR of 15.2%.

  • What are the key drivers of the bioprocess technology market?

The key drivers of the bioprocess technology market are increasing spending on life science research, strong biologics pipeline, and capital investments to aid advancements biotechnology.

  • What factors are driving demand for the bioprocess technology market?

Rising adoption of single-use (disposable) bioprocessing technology, growth in personalized treatment for rare diseases, and increase in the use of biosimilar are the major factors driving demand in the bioprocess technology market.

  • What is the market share of the top players in the bioprocess technology market?

The cumulative market share of the top players including Thermo Fisher Scientific Inc, Merck KgaA and Danaher Corporation holds around 65% of the overall market.

  • Who are the top 5 countries driving demand for the bioprocess technology market?

India, China, the U.S., Japan, and Germany are the top 5 countries that are driving the demand for bioprocess technology.

  • At what rate are the sales of bioprocess technology rising in North America?

North America will hold around 33.6% revenue share in the overall bioprocess technology market in 2021. The US remains the fastest growing market in North America, with the demand for bioprocess technology forecast to rise at a CAGR of 10.5% over the forecast period.

  • At what rate will the demand for bioprocess technology rise in Europe?

The Europe market is set to exhibit a CAGR of 14.1% during the forecast period owing to the high demand for cell development products and lab-scale bioreactors in the upstream segment.

SGLT2 Inhibitors Treatment Market Outlook Cover New Business Strategy with Upcoming Opportunity 2021 to 2031

The SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.

SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes across the globe is never-ending, thus leading to grow the market. The prevalence of people suffering from Diabetes is said to lead the market at another level.

What is driving Demand for SGLT2 Inhibitors Treatment Market?

The demand for this market has seen at a higher rate at a global level as there has been increase in the number of Diabetic cases with increase in the population. According to WHO data worldwide, the count in the cases is seen at a higher side i.e. from 2.8% in 2000 and by 2030 it is said to be 4.4%. According to the 29.1 million cases of people diagnosing with diabetes in the year 2010.

The changing lifestyle, obesity and sedentary lifestyle can be the causes for diabetes can demand the SGLT2 market. Population preferring simple and easy way of treatment can boost the market. Covid 19 has eventually driven the market growth as post covid complications has made it a necessity.  In addition, new combination drugs seems to drive the market. US and Europe has the highest number of morbid obesity cases which leads to Diabetes, can be the driving factor for the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14054

U.S. SGLT2 Inhibitors Treatment Market Outlook

  • North America occupies about 65% of the market share. US accounts for the highest number of type 2 diabetic cases owing to demand in the market growth. North America also has well established health a care structure. Canagliflozin saw an immense growth in the US, which was approved by US FDA. According the study on an average of 1.75 million US native is diagnosed with type 2 Diabetes, furthermore the population suffering from morbid obesity is one of the major reason to cause Diabetes. This gives us an open window to drive our market.

Europe Demand Outlook for SGLT2 Inhibitors Treatment Market

Empagliflozin is said to be the leading the market in Europe region and can be used in adults with low adverse effect. European commission has granted permission to market the product globally. EMPOWER program has been run so as to understand the efficacy of the Empagliflozin, this was brought in by Boehringer Ingelheim and Lilly.

Empagliflozon was the recent medicine to be approved by FDA in 2014. European Medicine Agency confirms that the SGLT 2 inihibitors can be used in treatment of Type 2 Diabetes. Europe has the highest rate of Diabetes cases which is fatal in nature and in the given forecast period it is said to reach an average of 10million cases.

Who are the Key Manufacturers and Suppliers of SGLT2 Inhibitors treatment market.

Some of the key players operating in the SGLT2 Inhibitors Treatment Market are

  • Eli Lilly and Company (The U.S),
  • C.H. Boehringer Sohn AG & Ko. KG (Germany),
  • Johnson & Johnson (The U.S),
  • AstraZeneca plc (UK),
  • The Merck Group (Germany),
  • Pfizer Inc. (The U.S),
  • Tecnimede Group (The U.S),
  • Unichem Laboratories Ltd. (India), and
  • Edifício Bluepharma (Portugal).

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14054

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Active Humidifier Devices Market Outlook Cover New Business Strategy with Upcoming Opportunity 2021 to 2031

According to a recent study by Future Market Insights (FMI), the active humidifier devices market is expected to witness sluggish growth during the forecast period. The market is slated to grow from US$ 1.23 Bn in 2020 to over US$ 1.0 Bn by 2031. This reflects a cumulative CAGR of around -2.2% over the forecast period (2021-2031).

The current market scenario depicts a competitive landscape and is anticipated to witness significant growth during the forecast period. Growing respiratory disorders across the globe due to the outbreak of COVID -19 virus, created a sharp rise in demand for ventilators across the globe.

As humidifiers are used to provide humidified air to patients who require respiratory assistance, the demand for these devices increased during the pandemic, especially across India, China, and the U.S. Also, the outbreak of infectious diseases affecting respiratory systems, acceptance of high flow nasal cannula for oxygen therapy is anticipated to drive the sales of active humidifier devices.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13929

Growing geriatric population with respiratory disorders has improved the adoption of non-invasive ventilators. However, due to increasing severe cases of COVID-19 across the globe, need for invasive heated/electronic humidifier devices have surged the sales worldwide.

As per Future Market Insights, invasive ventilation segment is accounted for over 46.8% during 2021 and is expected to witness steady growth during the forecast period. With high prevalence of air borne diseases and respiratory diseases, demand for heated/electronic active humidifier devices is expected to witness substantial growth over the forecast period.

The heated/electronic active humidifier devices will hold over 56.5% of global market share through 2031, estimated by Future Market Insights. In past, the development and launch of technologically advanced new solutions to meet patients’ expanding respiratory needs is expected to bolster active humidifier devices market growth.

active humidifier devices market characteristics and attributes with regional relevance 2021

Key Takeaways from Active Humidifier Devices Market Study

  • By product, heated/electronic humidifier devices accounted for the largest share of 56% in 2021 and are expected to continue to grow during the forecast period.
  • By age group, adult segment is expected to account for the largest share of 88% in 2021 of global active humidifier devices.
  • In terms of application, invasive ventilation is expected to account for the largest share of 47% during in 2021.
  • By end user, hospitals accounted for the largest share of 65% in 2021 and are expected to grow at the steady pace during the forecast period.
  • North America held the largest share of 28.7% in 2021 of the global active humidifier devices market. Emergence of new infectious diseases affecting respiratory systems, presence of leading manufacturers, and growing market consolidation activities has fueled the growth of the active humidifier devices market in North America.

“Surging demand amid COVID-19 outbreak and acceptance of high flow nasal cannula therapy will drive the humidifier devices market over the next ten years,” says the FMI Analyst

Who is winning?

Some of the leading manufacturers of active humidifier devices market are focusing on product launches and expansion strategies such as collaboration and mergers with other key players to expand their customer base, thereby, improving their market presence.

  • In July 2021, Breas Medical and Dräger entered into an agreement, together, wherein, they will provide extended support for providing ventilation solutions into the U.S. long-term care facilities.
  • In July 2021, Koninklijke Philips N.V.  announced the acquisition of Capsule Technologies, Inc. to expand its leadership in patient care management.
  • In April 2020, Vapotherm expanded its production capacity for high-flow nasal cannula systems, in response to the growing demand for high-flow nasal cannula systems, which are used for treating COVID -19 respiratory distress.
  • In May 2020, Inspired Medical’s Inspired O2FLO high flow respiratory humidifier has received Emergency Use Authorization (EUA) by U.S. FDA. This device will be available for emergency use in healthcare settings to treat patients with hypoxemia and other-acute respiratory symptoms. Additionally, O2FLO also meets homecare safety requirements which makes them safe for home use and also is IEC60601-11 compliant.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13929

The key market players profiled by FMI include Teleflex Incorporated, Koninklijke Philips N.V., Fisher & Paykel, ResMed, Vapotherm Inc., Vincent Medical Ltd (Inspired Medical), Sumed (Salter Labs), WLAMed GmbH, Penlon Ltd., DEAS S.R.L., Beijing Aeonmed Co., Ltd., Flexicare (Group) Limited, GalMed Corporation, and Vadi Medical Technologies.

What is the Impact of the COVID-19 on the Market? 

Adevnt of COVID-19 is anticipated to have a positive impact on the growth of the active humidification market, specifically for heated/electronic humidification devices. In the FQ-20, cases of coronavirus witnessed sudden spike, especially in India, which provided major boost to the active humidifier devices demand.

Also, even with the commencement of vaccination drive across the globe, cases are still increasing in some regions across the globe, which is keeping the market demand steady. Now, with growing awareness among the consumers for their health, as a precautionary measure consumers are increasing the adoption of these devices, especially for the patients in home-care settings.

Active Humidifier Devices by Category 

Product Type:

  • Heated/electronic Humidifiers
  • Bubble Humidifiers
  • Accessories

Age Group:  

  • Adult
  • Paediatric
  • Neonates

Application:

  • Invasive Ventilation
  • Non-invasive Ventilation
    • nCPAP (Nasal Continuous Positive Airway Pressure)
    • Bubble CPAP (Bubble Continuous Positive Airway Pressure)
  • High Flow Oxygen Therapy

End User:

  • Hospitals
    • Less than 100 Beds
    • 100-300 Beds
    • 300-500 Beds
    • 500 Beds and More
  • Ambulatory Surgical Centers
  • Sleep Centres

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in the Report

How much is the active humidifier devices market currently worth?

What are the key market statistics in China?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13929

Pelvic Floor Diagnostics Market Huge Growth Opportunity between 2021-2031

According to a recent report by Future Market Insights, the demand for pelvic floor diagnostics is expected to rise at a significant pace, enabling the market to reach US$ 3,313.4 Mn in valuation by the end of 2031.

The pelvic floor diagnostics market will witness strong demand owing to the prevalence of associated ailments especially in pregnant women, and increasing awareness levels towards pelvic floor diagnostic testing. The rise in adoption of advanced imaging systems is resulting in superior patient outcomes.

Developed economies such as the U.S. show an increasing trend of adoption of advanced diagnostic devices. Favorable reimbursement scenarios boost market growth. The healthcare and diagnostic infrastructure in the U.S. has advanced at an elevated rate due to increasing research and development activities pertaining to healthcare.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13752

Rising healthcare expenditure, along with growing government support by funding’s and faster approvals has led to the establishment of pelvic floor diagnostic laboratories and a larger number of professionals.

Rising number of grants by private and government players for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.

Healthcare standards with advanced diagnostic procedures have gained ground during the last two decades and with the rise in income and the increased investments in research. The pelvic floor diagnostics market has experienced a substantial shift in the adoption of molecular diagnostic devices.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13752

Key Takeaways from Pelvic Floor Diagnostics Market Study

  • Ultrasound systems are expected to reach a revenue share of 37.1% in 2021 with a growing CAGR of 5.7% during forecast period.
  • Hospitals will drive sales accounting for over 60% value share through 2031, owing to higher spending capacity.
  • Mexico will reflect a 6.1% CAGR through 2031, supported by growing access to superior medical facilities.
  • U.K. and France are leading markets in Europe, accounting for over 20% and over 18% of the Europe market respectively in 2021.
  • The U.S. is the largest and fastest growing market in North America, exhibiting 5.7% CAGR through the forecast period.

“The growing global geriatric population is prone to pelvic floor disorders. Consequently, advancements diagnostics including imaging and ultrasound systems, coupled with investments in research and academic bodies are set to boost the growth of pelvic floor diagnostics market over the coming decade,” says a Future Market Insights analyst.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13752

Investments in Tech Development to Offer Growth Opportunities

The pelvic floor diagnostics market has emerged as a lucrative area of research in terms of pelvic dysfunction. The development of imaging technology is gaining traction with the rising demand of high-resolution images.

The demand is fueled by increasing awareness among the growing population about the diagnostic options available. Ultrasound systems offer reliable high-resolution imaging. The evolution in the processes involving detection, diagnosis, and treatment of associated diseases is anticipated to cause a demand surge in the pelvic floor diagnostics market.

Who is winning?

Key players in the pelvic floor diagnostics market are focusing on tapping market potential through strategic mergers and acquisitions. This is driven by efficiency in innovative and specialized product portfolios. The market is also set to expand due to increasing activities in research and development to diagnose pelvic floor disorders.

Some of the leading players in the pelvic floor diagnostics market include but are not limited to Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.

High Flow Oxygen Therapy Devices Market Size Worth US$ 1.4 Bn by 2031

The rising prevalence of acute respiratory failures (ARF) due to the COVID-19 outbreak, risk of community infection, increasing demand for high flow nasal cannula, and advancements in high flow oxygen therapy devices are some key factors contributing to the growth of the high flow oxygen therapy devices market.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the high flow oxygen therapy devices market. Sales of high flow oxygen therapy devices are expected to top US$ 1.7 Bn in 2021, at a CAGR of -6.4% during 2021-2025 and CAGR of 1.4% during the forecast period (2025-2031).

Public health issues worldwide, including Acute Respiratory Failure (ARF), pneumonia, asthma, and interstitial lung disease, pose a significant socioeconomic burden on individuals and societies.

Presently, COVID-19 is the primary risk factor for ARF. COVID-19 symptoms such as low blood-oxygen level and pneumonia in patients increase the risk of ARFs. Because of the growing ageing population and increased exposure to risk factors, ARF and pneumonia are becoming more prominent problems across the world, which is fuelling the demand for high flow oxygen therapy devices.

The World Health Organization (WHO) Child Health Epidemiology Reference Group estimates that the pneumonia resulted 105.7 million new cases in 2017; of these 13% were severe and needed immediate hospitalization.

Consistent rise in incidence of pneumonia will fuel the demand for high floe oxygen therapy devices through the forecast period. Indoor air pollution was a major risk factor that was estimated to have led to 29% of pneumonia deaths in 2017.

Outdoor air pollution was responsible for another 18% of all deaths. In addition, an increase of 81.1% in the number of pneumoconiosis cases were observed for both sexes from 1990 to 2017 worldwide. Thus, the growing burden of respiratory diseases along with the outbreak of COVID-19 across the world is expected to drive the high flow oxygen therapy devices market.

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13794

Key Takeaways from High Flow Oxygen Therapy Devices Market Study

  • Demand for heated humidifiers is expected to grow at -6.6% CAGR during 2021-2025 and 1.3% CAGR through 2025-2031, owing to the occurrence of the COVID-19 pandemic.
  • The acute respiratory failure segment accounted for a higher share of 90% among applications. This can be due to the rising COVID-19 cases that lead to acute respiratory failure in the infected patients and require non-invasive respiratory support.
  • 500 Beds and Above Hospitals are projected to capture over 51% of the global market by 2031. This is attributed to the growing burden of respiratory diseases.
  • North America is the largest revenue-generating region for high flow oxygen therapy devices, with the U.S. accounting for nearly 96% of the regional market in 2031.
  • South Asia is the second most lucrative market with India accounting for over 58% of the share in 2031.
  • Japan holds the leading position in East Asia and is expected to account for over 42% of the market in 2031.

“Increasing funding for R&D activities aimed launching novel products and solutions and healthcare recognition and recommendation of high-flow nasal cannula oxygen therapy will continue creating growth opportunities for manufacturers through the assessment period, ending in 2031,” says the FMI analyst

Who is winning?

Some of the leading manufacturers of high flow oxygen therapy devices are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are also focusing on innovation and launching new technologies for increasing the efficiency of products.

  • In June 2020, Armstrong Medical introduced the second generation FD140i, an improved dual therapy flow driver with an easier transition from CPAP to HFOT.
  • In 2019, TherOx Company received approval for SuperSaturated Oxygen Therapy system from the U.S. Food and Drug Administration (FDA) to be one of the effective therapies for cardiovascular diseases.

The key market players covered by FMI include Draegerwerk AG & Co. KGaA, Teleflex Medical GmBH, Philips Respironics, Vapotherm, Inc., ResMed, Vyaire Medical, Inc., Fisher & Paykel Corporation Ltd., Armstrong Medical, Flexicare Medical, Hamilton Medical Inc., Intersurgical Inc., Inspired Medical, WILAMed GmBH, Besmed Health Business Corp, Shenzhen Micomme Medical Technology Development Co., Ltd, Shenyang RMS Medical Tech Co. Ltd. and BMC Medical Co., Ltd.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global high flow oxygen therapy devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on high flow oxygen therapy devices segment based on the product (High Flow Nasal Cannulas, High Flow Oxygen Masks, Breathing Circuits, Heated Humidifiers and Accessories) Application (Pneumonia and Acute Respiratory Failure) End User (Less than 100 Beds Hospitals, 100-250 Beds Hospitals, 250-500 Beds Hospitals and 500 Beds and Above Hospitals) across seven major regions.

Any Queries, Contact us @ https://www.futuremarketinsights.com/ask-question/rep-gb-13794

Key Questions Answered in Report

  • How much is the High Flow Oxygen Therapy Devices Market worth?

The high flow oxygen therapy devices market will reach worth of US$ 1.7 Bn in the year 2021 and is expected to reach US$ 1.4 Bn by 2031 owing to the rising prevalence of acute respiratory failures due to the covid-19 pandemic.

  • What is the demand outlook of the High Flow Oxygen Therapy Devices Market?

High flow oxygen therapy devices are projected to record high demand in the forecast period. The overall market is forecast to exhibit a CAGR of -6.4% during 2021-2025 and 1.4% from 2025-2031.

  • At what rate did the High Flow Oxygen Therapy Devices Market rise in the last 5 years?

Historically, the market has grown at a CAGR of 23.9% from 2016 to 2020.

  • What are the key trends of High Flow Oxygen Therapy Devices?

Growing community infection to increase high flow nasal cannula and continuous product development and new launches are some of the prominent trends which drive the demand for high flow oxygen therapy devices.

  • What factors are driving demand for High Flow Oxygen Therapy Devices?

The growing burden of respiratory diseases and increase in the ageing population are the major driving factors.

  • What is the market share of the top players in the High Flow Oxygen Therapy Devices Market?

The cumulative market share of the top players including Koninklijke Philips N.V., Fisher & Paykel Corporation Ltd., Resmed Corporation, Drägerwerk AG & Co. KGaA and Teleflex Corporation constitutes around 64.8% of the overall fragmented market.

  • What are the top 5 countries driving demand for High Flow Oxygen Therapy Devices?

India, China, the U.S., India, Japan, China and Germany are the top 5 countries that are driving the demand for High Flow Oxygen Therapy Devices.